MIDAS VERDICT:
Accrol operates in an essential and growing market. Jenkins is ambitious and the business has strong potential. At 52p, the shares are a buy.
Accrol operates in an essential and growing market. Jenkins is ambitious and the business has strong potential. At 52p, the shares are a buy.